Highlights Otsuka Corporation

Equities

4768

JP3188200004

Delayed Japan Exchange Other stock markets 11:30:00 10/05/2024 am IST			5-day change	1st Jan Change
2,994 ^JPY	-0.08%		-0.93%	+3.01%

30/04	Otsuka Holdings' Attributable Profit Jumps 26% in Q1	MT
29/04	Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Otsuka Holdings' Attributable Profit Jumps 26% in Q1	30/04	MT
Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	29/04	MT
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	09/04	MT
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	29/03	MT
Split: 2 of 1	28/03	FA
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	27/03	MT
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03	MT
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26/02	DJ
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02	MT
Otsuka Holdings Lowers 2023 Profit Outlook	13/02	MT
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	13/02	RE
Otsuka Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/02	CI
Final dividend	28/12	FA
Ionis Pharmaceuticals Signs Europe Licensing Deal With Otsuka for Donidalorsen in Hereditary Angioedema	19/12	MT
Otsuka Unit Buys New York-Based Provider of Women Health Products	05/12	MT
US FDA approves Medtronic's blood pressure treatment device for use	18/11	RE
Aurinia Pharmaceuticals Partner Otsuka Pharmaceutical Files New Drug Application For Voclosporin in Japan	13/11	MT
US FDA approves Otsuka's blood pressure treatment device for use	08/11	RE
Otsuka Holdings’ Attributable Profit up 45.6% in Nine-Month Period as Revenue Growth More than Offsets Impairment Losses	01/11	MT
Mindset Pharma Agrees to be Bought by Otsuka Pharmaceutical	31/23/31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Otsuka Corporation

Equities

4768

JP3188200004

Highlights

Filters